14 minutes | May 30th 2018

147 - Crizotinib breakthrough therapy designation; certolizumab for moderate-to-severe plaque psoriasis; Zeto wireless EEG headset; larotrectinib in solid tumors; Raviten for intradialytic hypotension

May 30, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:01 Pfizer’s XALKORI® (crizotinib) receives FDA breakthrough therapy designation in two new indications https://investors.pfizer.com/investor-news/press-release-details/2018/Pfizers-XALKORI-crizotinib-Receives-FDA-Breakthrough-Therapy-Designation-in-Two-New-Indications/default.aspx 3:14 UCB announces the approval of CIMZIA® (certolizumab pegol) for moderate-to-severe plaque psoriasis https://www.prnewswire.com/news-releases/ucb-announces-the-approval-of-cimzia-certolizumab-pegol-for-moderate-to-severe-plaque-psoriasis-representing-an-important-new-option-for-patients-in-the-us-300655645.html 5:29 Zeto announces first dry electrode, wireless EEG headset approved by FDA for clinical use https://www.prnewswire.com/news-releases/zeto-announces-first-dry-electrode-wireless-eeg-headset-approved-by-fda-for-clinical-use-300655286.html 7:40 FDA accepts larotrectinib new drug application and grants priority review solid tumors harboring https://www.prnewswire.com/news-releases/fda-accepts-larotrectinib-new-drug-application-and-grants-priority-review-300655627.html 10:17 TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten® https://www.prnewswire.com/news-releases/trioxbio-announces-fast-track-designation-granted-by-us-fda-to-raviten-for-the-treatment-of-intradialytic-hypotension-683935721.html  Please check out my weekly podcast AI in Medicine. In this week’s episode I talk to Chris Mansi who is CEO and co-founder of Viz.ai. Viz technology helps detect LVO and uses an AI algorithm to classify patients with stroke who need immediate treatment. Check it out at aimedicinenews.com Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Play
Like
Play Next
Mark
Played
Share